P120 Cardiac safety of pertuzumab, trastuzumab and standard chemotherapy as neoadjuvant treatment for HER2 positive breast cancer: real world data from NeoPowER trial. (April 2023) - Canino, F.; Barbolini, M.; De Giorgi, U.; Dominici, M.; Gianni, L.; Moscetti, L.; Omarini, C.; Zamagni, C.; Molinaro, A.; Antonelli, G.; Baglio, F.; Martinelli, G.; et al.